M. Ghandi et al. / Tetrahedron Letters 52 (2011) 6613–6615
6615
16. Culbertson, B. M.; Dietz, S. J. Chem. Soc. C 1968, 992–993.
styrenesulfonyl chlorides. The six-membered sultams were pre-
sumably obtained via N-sulfonylation—intramolecular Michael
addition sequences.
17. General procedure for the synthesis of sultam 5a. To a stirred solution of b-
ketoester 2a (1 mmol, 0.126 mL) was added amine 1a (1 mmol, 0.082 mL)
dropwise. Styrenesulfonyl chloride (4a) (1 mmol, 0.202 g) dissolved in CH2Cl2
(7 mL) was subsequently added and the mixture stirred for 12 h. After
completion of the reaction, the solvent was evaporated under reduced
pressure and the residue purified by column chromatography on silica gel
(230–400 mesh; Merck), using hexane–EtOAc (9:1) as eluent to give sultam 5a.
Acknowledgment
18. Ethyl
1,1-dioxide (5a).White solid, (258 mg, 76%), mp: 79–81 °C; IR (KBr)
(CO), 1323 (SO2), 1125 (SO2) cmÀ1 1H NMR (500 MHz, CDCl3)
3-methyl-5-phenyl-2-propyl-5,6-dihydro-2H-1,2-thiazine-4-carboxylate
: 1708
0.83 (t,
The authors acknowledge the University of Tehran for the finan-
cial support of this research.
m
.
d
J = 7.0 Hz, 3H, CH3CH2CH2N), 0.99 (t, J = 7.5 Hz, 3H, CH3CH2O), 1.73–1.75 (m,
2H, CH3CH2CH2N), 2.29 (d, J = 1.5 Hz, 3H, CH3C@C), 2.96 (dd, J = 13.2, 12.5 Hz,
1H, SO2CHHCHPh), 3.48–3.51 (m, 1H, SO2CHHCHPh), 3.52–3.54 (m, 1H,
CH3CH2CHHN), 3.72–3.77 (m, 1H, CH3CH2CHHN), 3.80 (q, J = 7.5, 2H,
CH3CH2O), 4.44–4.48 (m, 1H, SO2CH2CHPh), 7.21–7.33 (m, 5H, Ph); 13C NMR
(125 MHz, CDCl3) d 11.5 (CH3CH2CH2N), 13.9 (CH3CH2O), 19.3 (CH3C@C), 23.4
(CH3CH2CH2N), 44.2 (SO2CH2CHPh), 48.3 (CH3CH2CH2N), 53.8 (CH3CH2O), 60.8
(SO2CH2CHPh), 116.2 (NC@C), 144.53 (NC@C), 127.9, 127.9, 129.3, 141.0 (Ph),
167.4 (OC@O); MS (EI, 70 eV) m/z 337 (49, M+), 292 (21), 272 (17), 244 (76), 43
(100%); Anal. calcd for C17H23NO4S: C, 60.51; H, 6.87; N, 4.15. Found: C, 60.29;
H, 6.49; N, 4.25.
References and notes
1. (a) Drews, J. Science 2000, 287, 1960–1964; (b) Scozzafava, A.; Owa, T.;
Mastrolorenzo, A.; Supuran, C. T. Curr. Med. Chem. 2003, 10, 925–953.
2. (a) Silvestri, R.; Marfè, G.; Artico, M.; La Regina, G.; Lavecchia, A.; Novellino, E.;
Morgante, M.; Di Stefano, C.; Catalano, G.; Filomeni, G.; Abruzzese, E.; Ciriolo,
M. R.; Russo, M. A.; Amadori, S.; Cirilli, R.; La Torre, F.; Salimei, P. S. J. Med. Chem.
2006, 49, 5840–5844; (b) Lebegue, N.; Gallet, S.; Flouquet, N.; Carato, P.;
Pfeiffer, B.; Renard, P.; Leonce, S.; Pierre, A.; Chavatte, P.; Berthelot, P. J. Med.
Chem. 2005, 48, 7363–7373.
3. Tanimukai, H.; Inui, M.; Hariguchi, S.; Kaneko, Z. Biochem. Pharmacol. 1965, 14,
961–970.
4. Rabasseda, X.; Hopkins, S. J. Drugs Today 1994, 30, 557–561.
5. Brzozowski, F.; Saczewski, F.; Neamati, N. Bioorg. Med. Chem. Lett. 2006, 16,
5298–5302.
19. (a) Ethyl 2-benzyl-3-methyl-5-phenyl-5,6-dihydro-2H-1,2-thiazine-4-carboxylate
1,1-dioxide (5e). White solid (281 mg, 73%); mp: 108–110 °C; IR (KBr)
m
: 1715
(CO), 1346 (SO2); 1158 (SO2) cmÀ1 1H NMR (500 MHz, CDCl3)
;
d 0.86 (t,
J = 7.0 Hz, 3H, CH3CH2O), 2.39 (d, J = 2.0 Hz, 3H, CH3C@C), 2.59 (dd, J = 13.3,
12.5 Hz, 1H, SO2CHHCHPh), 3.37–3.41 (m, 1H, SO2CHHCHPh), 3.85 (q,
J = 7.0 Hz, 2H, CH3CH2O), 4.38–4.42 (m, 1H, SO2CH2CHPh), 4.79 (d,
J = 16.0 Hz, 1H, PhCHHN), 5.01 (d, J = 16.0 Hz, 1H, PhCHHN), 6.91–7.47 (m,
6. (a) Dauban, P.; Dodd, R. H. Org. Lett. 2008, 10, 2223–2226; (b) Davis, F. A.; Chen,
B.-C. Chem. Rev. 1992, 92, 919–934; (c) Differding, E.; Lang, R. Helv. Chim. Acta
1989, 72, 1248–1252.
10H); 13C NMR (125 MHz,CDCl3)
d 13.9 (CH3CH2O), 20.0 (CH3C@C), 44.1
(SO2CH2CHPh), 50.3 (PhCH2N), 53.5 (CH3CH2O), 60.9 (SO2CH2CHPh), 118.6
(NC@C), 144.1 (NC@C), 127.8, 127.9, 128.8, 128.9, 129.2, 129.4, 135.7, 140.5,
167.1 (OC@O); MS (EI, 70 eV) m/z 385 (4, M+), 351 (27), 258 (55), 214 (43), 91
(100%). Anal. calcd for C21H23NO4S: C, 65.43; H, 6.01; N, 3.63. Found: C, 65.12;
H, 6.23; N, 3.86; (b) 1-[5-(4-bromophenyl)-3-methyl-2-propyl-5,6-dihydro-2H-
1,2-thiazin-4-yl]ethanone 1,1-dioxide (5m). Cream solid, (296 mg, 77%); mp:
7. (a) Bravo, R. D.; Canepa, A. S. Synth. Commun. 2002, 32, 3675–3680; (b) Orazi, O.
O.; Corral, R. A.; Bravo, R. J. Heterocycl. Chem. 1986, 23, 1701–1708; (c)
Katritzky, A. R.; Wu, J.; Rachwal, S.; Rachwal, B.; Macomber, D. W.; Smith, T. P.
Org. Prep. Proced. Int. 1992, 24, 463–467.
8. Lee, J.; Zhong, Y.-L.; Reamer, R. A.; Askin, D. Org. Lett. 2003, 5, 4175–4177.
9. Enders, D.; Moll, A.; Bats, J. W. Eur. J. Org. Chem. 2006, 1271–1284.
10. Chiacchio, U.; Corsaro, A.; Rescifina, A.; Bkaithan, M.; Grassi, G.; Piperno, A.
Tetrahedron 2001, 57, 3425–3433.
105–108 °C; IR (KBr)
m
1725 (CO), 1346 (SO2); 1146 (SO2) cmÀ1
;
1H NMR
(500 MHz, CDCl3)
d
0.98 (t, J = 7.3 Hz, 3H, CH3CH2CH2N), 1.71–1.78 (m,
J = 7.6 Hz, 2H, CH3CH2CH2N), 1.98 (s, 3H, CH3C@C), 2.13 (s, 3H, CH3CO), 2.92
(t, J = 12.7 Hz, 1H, SO2CHHCHPh), 3.46–3.50 (m, 1H, SO2CHHCHPh), 3.51–3.54
(m, 1H, CH3CH2CHHN), 3.69–3.73 (m, 1H, CH3CH2CHHN), 4.43–4.47 (m, 1H,
SO2CH2CHPh), 7.10 (d, J = 8.2 Hz, 2H, Ph), 7.40 (d, J = 8.2 Hz, 2H, Ph); 13C NMR
(125 MHz,CDCl3) d 11.5 (CH3CH2CH2N), 19.6 (CH3C@C), 23.4 (CH3CH2CH2N),
30.8 (CH3CO), 43.7 (SO2CH2CHPh), 48.4 (CH3CH2CH2N), 53.8 (SO2CH2CHPh),
122.4 (NC@C), 141.2 (NC@C), 129.9, 133.0, 133.2, 138.7, 201.8 (C@O); MS (EI,
11. (a) Metz, P.; Seng, D.; Fröhlich, R. Synlett 1996, 741–742; (b) Plietker, B.; Seng,
D.; Fröhlich, R.; Metz, P. Tetrahedron 2000, 56, 873–879; (c) Rogatchov, V. O.;
Bernsmann, H.; Schwab, P.; Fröhlich, R.; Wibbeling, B.; Metz, P. Tetrahedron
Lett. 2002, 43, 4753–4756; (d) Greig, I. R.; Trozer, M. J.; Wright, P. T. Org. Lett.
2001, 3, 369–371; (e) Wanner, J.; Harned, A. M.; Probst, D. A.; Poon, K. W. C.;
Klein, T. A.; Snelgrove, K. A.; Hanson, P. R. Tetrahedron Lett. 2002, 43, 917–921.
12. (a) Merten, S.; Fröhlich, R.; Kataeva, O. Adv. Synth. Catal. 2005, 347, 754–758;
(b) Vasudevan, A.; Tseng, P.-S.; Djuric, S. W. Tetrahedron Lett. 2006, 47, 8591–
8593.
13. Liu, X.-Y.; Li, C.-H.; Che, C.-M. Org. Lett. 2006, 8, 2707–2710.
14. (a) Dauban, P.; Dodd, R. H. Org. Lett. 2000, 2, 2327–2329; (b) Dauban, P.;
Sanière, L.; Aurélie, T.; Dodd, R. H. J. Am. Chem. Soc. 2001, 123, 7707–7708; (c)
Sherman, E. S.; Chemler, S. R.; Tan, T. B.; Gerlits, O. Org. Lett. 2004, 6, 1573–
1575; (d) Zeng, W.; Chemler, S. R. J. Am. Chem. Soc. 2007, 129, 12948–12949.
15. (a) Liang, J.-L.; Yuan, S.-X.; Chan, P. W. H.; Che, C.-M. Org. Lett. 2002, 4, 4507–
4510; (b) Padwa, A.; Flick, A. C.; Leverett, C. A.; Stengel, T. J. Org. Chem. 2004, 69,
6377–6386.
70 eV) m/z 387 [20, M+ 81Br)], 385 [52, M+ 79Br)], 329 (61), 250 (55), 236 (94),
( (
41 (100%). Anal. calcd for C16H20BrNO3S: C, 49.75; H, 5.22; N, 3.63. Found: C,
50.12; H, 5.18; N, 3.43.
20. Crystallographic data for 5m have been deposited at the Cambridge
Crystallographic Data Centre with the deposition number CCDC 844991.
Copies of these data can be obtained free of charge via http://
(or
from
the
Cambridge
Crystallographic Data Centre, 12 Union Road, Cambridge, CB2 1EZ, UK; fax:
+44 1223 336 033; or e-mail:deposit@ccdc.cam.ac.uk).